Donor lymphocyte infusion can eliminate mixed chimerism in nonmyeloablative stem cell transplantation for correction of hyper-IgM syndrome

Acta Haematologica

Volumn 114, Issue 3, 2005, Pages 174-176

  Hongeng, Suradej ^a   Pakakasama, Samart ^a   Benjaponpitak, Suwat ^a   Kamchaisatian, Wasu ^a   Chaisiripoomkere, Watana ^a   Direkwatanachai, Chalerat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TETANUS TOXOID;

ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CHIMERA; DONOR; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; HYPERIMMUNOGLOBULINEMIA M; LYMPHOCYTE; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

CHILD, PRESCHOOL; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; LYMPHOCYTE TRANSFUSION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SYNDROME; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 27544440138     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087895     Document Type: Article

References (10)

1. Rosen FS, Cooper MD, Wedgwood RJ: The primary immunodeficiency. N Engl J Med 1995;333:431-440.
2. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 2001;98:12614-12619.
3. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
4. Thomas C, de Saint Basile G, Le Deist F, Theophile D, Benkerrou M, Haddad E, Blanche S, Fischer A: Brief report: correction of X-linked hyper-IgM syndrome by allogenic bone marrow transplantation. New Engl J Med 1995;333:426-429.
5. Amrolia P, Gaspar HB, Hassan A, Webb D, Jones A, Sturt N, Mieli-Vergani G, Pagliuca A, Mufti G, Hadzic N, Davies G, Veys P: Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000;96:1239-1246.
6. Jacobsohn DA, Emerick KM, Scholl P, Melin-Aldana H, O'Gorman M, Duerst R, Kletzel M: Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin M syndrome with cholangiopathy. Pediatrics 2004;113:122-127.
7. Jacobsohn DA, Duerst R, Tse W, Kletzel M: Reduced intensity haematopoietic stem-cell transplantation for treatment of non-malignant disease in children. Lancet 2004;364:156-162.
8. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997;158:977-983.
9. Sullivan KM, Parkman R, Walters MC: Bone marrow transplantation for non-malignant disease. Hematology (Am Soc Hematol Educ Program) 2000:319-338.
10. Tomizawa D, Imai K, Ito S, Kajiwara M, Minegishi Y, Nagasawa M, Morio T, Nonoyama S, Mizutani S: Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience. Am J Hematol 2004;76:33-39.